Editing Erythromycin (section)

== Medical uses ==
Erythromycin can be used to treat bacteria responsible for causing infections of the skin and upper respiratory tract, including ''[[Streptococcus]]'', ''[[Staphylococcus]]'', ''[[Haemophilus]]'' and [[Erythrasma|''Corynebacterium'']] genera. The following represents MIC susceptibility data for a few medically significant bacteria:<ref name = "www.toku-e.com">{{cite web | url = http://www.toku-e.com/Assets/MIC/Erythromycin.pdf | title = Erythromycin Susceptibility and Minimum Inhibitory Concentration (MIC) Data | publisher = TOKU-E | access-date = 26 February 2014 | archive-date = 9 May 2015 | archive-url = https://web.archive.org/web/20150509091111/http://www.toku-e.com/Assets/MIC/Erythromycin.pdf | url-status = live }}</ref>
* ''Haemophilus influenzae'': 0.015 to 256&nbsp;μg/ml
* ''Staphylococcus aureus'': 0.023 to 1024&nbsp;μg/ml
* ''Streptococcus pyogenes'': 0.004 to 256&nbsp;μg/ml
* ''Corynebacterium minutissimum'': 0.015 to 64&nbsp;μg/ml

It may be useful in treating [[gastroparesis]] due to this promotility effect. It has been shown to improve feeding intolerances in those who are critically ill.<ref>{{cite journal | vauthors = Lewis K, Alqahtani Z, Mcintyre L, Almenawer S, Alshamsi F, Rhodes A, Evans L, Angus DC, Alhazzani W | title = The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials | journal = Critical Care | volume = 20 | issue = 1 | pages = 259 | date = August 2016 | pmid = 27527069 | pmc = 4986344 | doi = 10.1186/s13054-016-1441-z | doi-access = free }}</ref> Intravenous erythromycin may also be used in [[esophagogastroduodenoscopy|endoscopy]] to help clear [[stomach]] contents to enhance endoscopic visualization, potentially improving diagnostic accuracy and subsequent management.<ref>{{cite journal | vauthors = Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI | title = ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding | journal = The American Journal of Gastroenterology | volume = 116 | issue = 5 | pages = 899–917 | date = May 2021 | pmid = 33929377 | doi = 10.14309/ajg.0000000000001245 }}</ref>

=== Available forms ===
[[File:000719lg Enteric coated erythomycin.jpg|thumb|Enteric-coated erythromycin capsule from Abbott Labs]]
Erythromycin is available in [[enteric coating|enteric-coated]] tablets, slow-release capsules, oral suspensions, ophthalmic solutions, ointments, gels, enteric-coated capsules, non enteric-coated tablets, non enteric-coated capsules, and injections.
The following erythromycin combinations are available for oral dosage:<ref name=drugs.com>{{cite web | url = https://www.drugs.com/cons/erythromycin-oral-parenteral.html | title = Erythromycin Oral, Parenteral Advanced Patient Information | work = Drugs.com | url-status = live | archive-url = https://web.archive.org/web/20091130183915/http://www.drugs.com/cons/erythromycin-oral-parenteral.html | archive-date = 30 November 2009 }}</ref>
* erythromycin base (capsules, tablets)
* erythromycin estolate (capsules, oral suspension, tablets), contraindicated during pregnancy<ref name="pmid16888612">{{cite journal | vauthors = Workowski KA, Berman SM | title = Sexually transmitted diseases treatment guidelines, 2006 | journal = MMWR: Recommendations and Reports | volume = 55 | issue = RR-11 | pages = 1–94 | date = August 2006 | pmid = 16888612 | doi = | url = https://www.cdc.gov/std/treatment/2006/toc.htm | archive-url = https://web.archive.org/web/20100211154655/http://www.cdc.gov/std/treatment/2006/toc.htm | archive-date=11 February 2010}}</ref>
* erythromycin ethylsuccinate (oral suspension, tablets)
* erythromycin stearate (oral suspension, tablets)
For injection, the available combinations are:<ref name=drugs.com/>
* erythromycin gluceptate
* erythromycin lactobionate

For ophthalmic use:
* erythromycin base (ointment)